erbB-2 Overexpression in Human Mammary Epithelial Cells Confers Growth Factor Independence*-Reference-Cited by-同舟云学术

erbB-2 Overexpression in Human Mammary Epithelial Cells Confers Growth Factor Independence*

Published:1999-08-01 Issue:8 Volume:140 Page:3615-3622
ISSN:0013-7227
Container-title:Endocrinology
language:en
Short-container-title:

Author:

Ignatoski Kathleen M. Woods¹,LaPointe Allison J.¹,Radany Eric H.¹,Ethier Stephen P.¹

Affiliation:

1. Department of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Medical School, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109-0948

Publisher

The Endocrine Society

Subject

Endocrinology

Link

http://academic.oup.com/endo/article-pdf/140/8/3615/10380099/endo3615.pdf

Reference55 articles.

1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.;Slamon;Science,1987

2. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.;Berger;Cancer Res,1988

3. Structure and expression of c-erbB-2 and EGF receptor genes inflammatory and non-inflammatory breast cancer: prognostic significance.;Guerin;Int J Cancer,1989

4. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms.;Kraus;EMBO J,1987

5. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases.;Lacroix;Oncogene,1989

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model;Oncotarget;2022-02-16

2. HER2 Activation and Endocrine Treatment Resistance in HER2-negative Breast Cancer;Endocrinology;2021-07-28

3. Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones;Journal of Clinical Investigation;2021-03-15

4. PIK3CA Cooperates with KRAS to Promote MYC Activity and Tumorigenesis via the Bromodomain Protein BRD9;Cancers;2019-10-24

5. Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway;Breast Cancer Research and Treatment;2019-06-17